Artificial intelligence-assisted diagnosis of early allograft dysfunction based on ultrasound image and data.

Journal: Visual computing for industry, biomedicine, and art
Published Date:

Abstract

Early allograft dysfunction (EAD) significantly affects liver transplantation prognosis. This study evaluated the effectiveness of artificial intelligence (AI)-assisted methods in accurately diagnosing EAD and identifying its causes. The primary metric for assessing the accuracy was the area under the receiver operating characteristic curve (AUC). Accuracy, sensitivity, and specificity were calculated and analyzed to compare the performance of the AI models with each other and with radiologists. EAD classification followed the criteria established by Olthoff et al. A total of 582 liver transplant patients who underwent transplantation between December 2012 and June 2021 were selected. Among these, 117 patients (mean age 33.5 ± 26.5 years, 80 men) were evaluated. The ultrasound parameters, images, and clinical information of patients were extracted from the database to train the AI model. The AUC for the ultrasound-spectrogram fusion network constructed from four ultrasound images and medical data was 0.968 (95%CI: 0.940, 0.991), outperforming radiologists by 30% for all metrics. AI assistance significantly improved diagnostic accuracy, sensitivity, and specificity (P < 0.050) for both experienced and less-experienced physicians. EAD lacks efficient diagnosis and causation analysis methods. The integration of AI and ultrasound enhances diagnostic accuracy and causation analysis. By modeling only images and data related to blood flow, the AI model effectively analyzed patients with EAD caused by abnormal blood supply. Our model can assist radiologists in reducing judgment discrepancies, potentially benefitting patients with EAD in underdeveloped regions. Furthermore, it enables targeted treatment for those with abnormal blood supply.

Authors

  • Yaqing Meng
    CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, 100190, China.
  • Mingyang Wang
    Department of Ultrasound, Tianjin First Central Hospital, NanKai University, Tianjin, 300192, China.
  • Ningning Niu
    Department of Ultrasound, Tianjin First Central Hospital, NanKai University, Tianjin, 300192, China.
  • Haoyan Zhang
    CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, 100190, China.
  • Jinghan Yang
    CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, 100190, China.
  • Guoying Zhang
    Department of Urology, The Affiliated Tumor Hospital of Kunming Medical University, Kunming 650118, China.
  • Jing Liu
    Department of Ophthalmology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
  • Ying Tang
    Department of Ultrasound, Tianjin First Central Hospital, NanKai University, Tianjin, 300192, China. drtang2002@aliyun.com.
  • Kun Wang
    CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing 100190, China.

Keywords

No keywords available for this article.